These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28574613)

  • 1. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
    Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
    Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cells.
    Tan MY; Mu XY; Liu B; Wang Y; Bao ED; Qiu JX; Fan Y
    Cell Physiol Biochem; 2013; 32(3):542-8. PubMed ID: 24008762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12.
    Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y
    Clin Cancer Res; 2014 Mar; 20(6):1531-41. PubMed ID: 24449823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis.
    Chang CC; Huang YS; Lin YM; Lin CJ; Jeng JC; Liu SM; Ho TL; Chang RT; Changou CA; Ho CC; Shih HM
    Sci Rep; 2018 Jun; 8(1):9786. PubMed ID: 29955155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.
    Tan M; Gong H; Wang J; Tao L; Xu D; Bao E; Liu Z; Qiu J
    Sci Rep; 2015 Sep; 5():13996. PubMed ID: 26369384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
    Yang X; Shi L; Yi C; Yang Y; Chang L; Song D
    Int J Urol; 2018 Feb; 25(2):157-163. PubMed ID: 29117631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway.
    Yang HJ; Liu GL; Liu B; Liu T
    J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
    Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX
    Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling.
    Tan M; Gong H; Zeng Y; Tao L; Wang J; Jiang J; Xu D; Bao E; Qiu J; Liu Z
    J Cell Biochem; 2014 Oct; 115(10):1762-7. PubMed ID: 24824041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor 8 induces SKOV3 ovarian cancer cell migration and E-cadherin down-regulation.
    Zhao J; Klausen C; Xiong S; Cheng JC; Chang HM; Leung PC
    Cell Signal; 2016 Nov; 28(11):1615-22. PubMed ID: 27481097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-linked kinase regulates cadherin switch in bladder cancer.
    Gil D; Ciołczyk-Wierzbicka D; Dulińska-Litewka J; Laidler P
    Tumour Biol; 2016 Nov; 37(11):15185-15191. PubMed ID: 27683053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.
    Zhuang X; Lv M; Zhong Z; Zhang L; Jiang R; Chen J
    J Exp Clin Cancer Res; 2016 Aug; 35(1):130. PubMed ID: 27576342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model.
    Liang Y; Zhu F; Zhang H; Chen D; Zhang X; Gao Q; Li Y
    Sci Rep; 2016 Jul; 6():29479. PubMed ID: 27378170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
    Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
    Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.